Patients with good physical condition, having no peritoneal metastases, low malignancy, and response to TCX chemotherapy had a longer overall survival.. - The study showed that the toxicity of TCX regimen in the treatment of patients with advanced gastric cancer were lower than those of other three-drug regimen in both frequency and severity of symptoms.